{
 "source": "Assay Systems register, https://assay-systems.com/register/",
 "key_tier": "none",
 "data": {
  "url": "https://assay-systems.com/register/ca/grants/r/solaeromed-inc/",
  "assay_record": "ASY-CA-1KR2GXF1KZ",
  "summary": "9 federal grant and contribution agreements worth $1.2M with SOLAEROMED INC., 2011–2019.",
  "name": "SOLAEROMED INC.: federal grants and contributions",
  "register": "",
  "dates": [],
  "tiles": [],
  "sections": [],
  "figures": [
   {
    "value": "9",
    "label": "agreements"
   },
   {
    "value": "$1.2M",
    "label": "value"
   },
   {
    "value": "1",
    "label": "departments"
   },
   {
    "value": "1",
    "label": "programs"
   }
  ],
  "text": [
   "SolAeroMed Inc is developing respiratory based technologies spun out of the University of Calgary. The project will support a proof of concept study to evaluate the firm's lead drug S1226 in Cystic Fibrosis (CF)."
  ],
  "records": [
   {
    "name": "grants and contributions register",
    "url": "https://assay-systems.com/register/ca/grants/"
   },
   {
    "name": "Calgary Centre",
    "url": "https://assay-systems.com/register/ca/grants/riding/48004-calgary-centre/"
   },
   {
    "name": "National Research Council Canada",
    "url": "https://assay-systems.com/register/ca/grants/department/national-research-council-canada/"
   }
  ],
  "cite_as": "Assay Systems, \"SOLAEROMED INC.: federal grants and contributions\", https://assay-systems.com/register/ca/grants/r/solaeromed-inc/"
 }
}